The effect of opioids on driving and psychomotor performance in patients with chronic pain

Clinical Journal of Pain

Volumn 21, Issue 4, 2005, Pages 345-352

  Byas Smith, Michael G ^a,c   Chapman, Stanley L ^a   Reed, Barbara ^a   Cotsonis, George ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

^c EMORY UNIVERSITY HOSPITAL   (United States)

Author keywords

Analgesics; Driving; Opioids; Pain; Psychomotor performance

Indexed keywords

AMITRIPTYLINE; BACLOFEN; CARISOPRODOL; CELECOXIB; CITALOPRAM; CODEINE; CYCLOBENZAPRINE; DEXAMPHETAMINE; DEXTROPROPOXYPHENE; DIHYDROMORPHINE; DOXEPIN; FLUOXETINE; GABAPENTIN; HYDROCODONE; METHADONE; MIRTAZAPINE; MORPHINE; NAPROXEN; NORTRIPTYLINE; OPIATE; OXYCODONE; PARACETAMOL; PAROXETINE; PETHIDINE; PHENYTOIN; ROFECOXIB; SERTRALINE; TIZANIDINE; TRAMADOL; VENLAFAXINE;

ADULT; ARTICLE; CHRONIC PAIN; CONTROLLED STUDY; DRIVING ABILITY; DRUG EFFECT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSYCHOMOTOR PERFORMANCE; SCORING SYSTEM; VELOCITY;

ACCIDENTS, TRAFFIC; ADULT; ANALGESICS, OPIOID; ANALYSIS OF VARIANCE; ATTENTION; AUTOMOBILE DRIVING; CHRONIC DISEASE; FEMALE; HUMANS; HYDROMORPHONE; MALE; MIDDLE AGED; MORPHINE; PAIN; PSYCHOMOTOR PERFORMANCE; REACTION TIME; WEATHER; WECHSLER SCALES;

EID: 21144435425     PISSN: 07498047     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ajp.0000125244.29279.c1     Document Type: Article

References (26)

1. Ramaekers JG. Antidepressants and driver impairment: empirical evidence from a standard on-the-road test. J Clin Psychiatry. 2003;64:20-29.
2. Zacny JP, Lichtor JL, Flemming D, et al. A dose-response analysis of the subjective, psychomotor and physiological effects of intravenous morphine in healthy volunteers. J Pharmacol Exp Ther. 1994;268:1-9.
3. Mitka M. Experts debate widening use of opioid drugs for chronic non-malignant pain. JAMA. 2003;289:2347-2348.
4. Meijler WJ. [Driving ban for patients on chronic opioid therapy unfounded]. Ned Tijdschr Geneeskd. 2000;144:1644-1645.
5. Hanks GW. Morphine sans morpheus. Lancet. 1995;346:652-653.
6. DUI Detection and Standardized Field Sobriety Testing. Atlanta, GA: Georgia Police Academy; 2000.
7. Greenberg L, Leark R, Dupuy T, et al. Test of Variables of Attention (TOVA and TOVA-A). Los Alamitos, CA: Universal Attention Disorders Inc.; 1996.
8. Koelega HS. Alcohol and vigilance performance: a review. Psychopharmacology (Berl). 1995;118:233-249.
9. Greenberg L, Leark R, Dupuy T, et al. Test of Variables of Attention (TOVA). Los Alamitos, CA: Universal Attention Disorders Inc; 1996.
10. Haythornthwaite JA, Menefee LA, Quatrano-Piacentini AL, et al. Outcome of chronic opioid Therapy for non-cancer pain. J Pain Symptom Manage. 1998;15:185-194.
11. Galski T, Williams JB, Ehle HT. Effects of opioids on driving ability. J Pain Symptom Manage. 2000;19:200-208.
12. Chapman SL, Byas-Smith MG, Reed BA. Effects of intermediate- and long-term use of opioids on cognition in patients with chronic pain. Clin J Pain. 2002;18:S83-S90.
13. Powell NB, Riley RW, Schechtman KB, et al. A comparative model: reaction time performance in sleep-disordered breathing versus alcohol-impaired controls. Laryngoscope. 1999;109:1648-1654.
14. Rosenzweig P, Patat A. Lack of behavioural toxicity of mizolastine: a review of the clinical pharmacology studies. Clin Exp Allergy. 1999;29(suppl 3):156-162.
15. Kearney SA, Guppy A. The effects of alcohol on speed perception in a closed-course driving situation. J Stud Alcohol. 1988;49:340-345.
16. Ramaekers JG, Robbe HW, O'Hanlon JF. Marijuana, alcohol and actual driving performance. Hum Psychopharmacol. 2000;15:551-558.
17. Bruera E, Macmillan K, Hanson J, et al. The cognitive effects of the administration of narcotic analgesics in patients with cancer pain. Pain. 1989;39:13-16.
18. Vainio A, Ollila J, Matikainen E, et al. Driving ability in cancer patients receiving long-term morphine analgesia. Lancet. 1995;346:667-670.
19. Zacny JP. A review of the effects of opioids on psychomotor and cognitive function in humans. Exp Clin Psychopharmacol. 1995;3:432-466.
20. Zacny JP. Should people taking opioids for medical reasons be allowed to work and drive? Addiction. 1996;91:1581-1584.
21. Ramaekers G, Lamers J, Verhey F, et al. A comparative study of the effects of carbamazepine and the NMDA receptor antagonist remacemide on road tracking and car-following performance in actual traffic. Psycho pharmacology (Berl). 2002;159:203-210.
22. Reynaud M, Le Breton P, Gilot B, et al. Alcohol is the main factor in excess traffic accident fatalities in France. Alcohol Clin Exp Res. 2002;26:1833-1839.
23. Leark R, Dupuy T, Greenberg L, et al. Professional Manual. Los Alamitos, CA: Universal Attention Disorders Inc.; 1999.
24. Attwood DA, Williams RD, Madill HD. Effects of moderate blood alcohol concentrations on closed-course driving performance. J Stud Alcohol. 1980;41:623-634.
25. Gawron VJ, Ranney TA. The effects of alcohol dosing on driving performance on a closed course and in a driving simulator. Ergonomics. 1988;31:1219-1244.
26. Wood MM, Ashby MA, Somogyi AA, et al. Neuropsychological and pharmacokinetic assessment of hospice inpatients receiving morphine. J Pain Symptom Manage. 1998;16:112-120.